Average Co-Inventor Count = 10.59
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (13 from 3,923 patents)
2. University of Pennsylvania (7 from 2,622 patents)
13 patents:
1. 12383601 - Chimeric antigen receptors and uses thereof
2. 12344657 - CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell
3. 12275795 - Binding molecules against BCMA and uses thereof
4. 11952428 - BCMA chimeric antigen receptors and uses thereof
5. 11939389 - BCMA chimeric antigen receptors and uses thereof
6. RE49847 - Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain
7. 11872249 - Method of treating cancer by administering immune effector cells expressing a chimeric antigen receptor comprising a CD20 binding domain
8. 11608382 - BCMA chimeric antigen receptors and uses thereof
9. 11492409 - Binding molecules against BCMA and uses thereof
10. 11149076 - CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell
11. 11026976 - Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain
12. 10525083 - Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domain
13. 10253086 - CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell